Evaluation of 2,3-dihydroimidazo[2,1-]oxazole and imidazo[2,1-]oxazole derivatives as chemotherapeutic agents.

Imidazo[2,1-]oxazole and 2,3-dihydroimidazo[2,1-]oxazole ring systems are commonly employed in therapeutically active molecules. In this article, the authors review the utilization of these core scaffolds as chemotherapeutic agents from 2018 to 2022. These scaffolds possess many important biological activities including antimicrobial and anticancer, among others.